Malgorzata Czyz

27PUBLICATIONS
26CO-AUTHORS
Molecular targetsReaction engineering (excl. nuclear reactions)Oncology and carcinogenesis not elsewhere classifiedPredictive and prognostic markersProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Nov 13, 2025
Cellular and Molecular Effects of Targeting the CBP/β-Catenin Interaction with PRI-724 in Melanoma Cells, Drug-Naïve and Resistant to Inhibitors of BRAFV600 and MEK1/2.

Anna Gajos-Michniewicz, Michal Wozniak, Katarzyna Anna Kluszczynska

|Jan 08, 2025
Exploring oncogenic roles and clinical significance of EZH2: focus on non-canonical activities.

Michal Wozniak, Malgorzata Czyz

|Dec 17, 2024
Therapeutic Potential of Natural Compounds to Modulate WNT/β-Catenin Signaling in Cancer: Current State of Art and Challenges.

Anna Gajos-Michniewicz, Malgorzata Czyz

|Oct 14, 2023
Pro-Apoptotic Activity of MCL-1 Inhibitor in Trametinib-Resistant Melanoma Cells Depends on Their Phenotypes and Is Modulated by Reversible Alterations Induced by Trametinib Withdrawal.

Mariusz L Hartman, Paulina Koziej, Katarzyna Kluszczyńska

|Jun 28, 2023
Histone Deacetylases (HDAC) Inhibitor-Valproic Acid Sensitizes Human Melanoma Cells to Dacarbazine and PARP Inhibitor.

Małgorzata Drzewiecka, Anna Gajos-Michniewicz, Grażyna Hoser

|May 13, 2023
Trametinib-Resistant Melanoma Cells Displaying MITFhigh/NGFRlow/IL-8low Phenotype Are Highly Responsive to Alternating Periods of Drug Withdrawal and Drug Rechallenge.

Paulina Koziej, Katarzyna Kluszczynska, Mariusz L Hartman

Pageof 5

Frequent Collaborators

9 joint publications

Mariusz L Hartman

4 joint publications

Malgorzata Sztiller-Sikorska

4 joint publications

Michal Wozniak

4 joint publications

Katarzyna Kluszczynska